~~<i id='2C1B280CCC'><strike id='2C1B280CCC'><tt id='2C1B280CCC'><pre id='2C1B280CCC'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

hotspot

author：hotspot 2025-09-06 01:57:53 - browse：1

Adam's take main illustration — Molly Ferguson/STAT

Shares of Apellis Pharmaceuticals are rebounding, driven by a growing belief among some investors that the serious safety issue that has derailed Syfovre, the company’s eye disease treatment, is receding.

Declaring the crisis over is premature, but that could change with more uneventful weeks. Apellis has been a takeout target before, and may be again, at an acquisition price nearly twice its current market value.

Apellis shares rose 32% last week, with most of the gains coming Friday on heavy trading volume. The reason: There have been no new cases of retinal occlusive vasculitis, or ROV, reported in people receiving injections of Syfovre.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： First over

hotspot

knowledge

leisure time

hotspot

leisure time

hotspot

WellcomeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletteri

WSS

Swim instructor mom warns parents not to buy blue swimsuits for kids

For AI in health care standards, federal regulators join with industry group

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Biden targets hefty hospital 'facility fees' that often surprise patients

Parents surprise family after baby discharged from NICU after 170 days

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

leisure time

hotspot

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Florida health officials providing scant details on measles cases

Apple is now the first public company to be valued at $3 trillion

The U.S. needs a new definition of substance use “recovery”

Sports medicine is finally prioritizing gender equality

Judge agrees to delay next hearing in Trump classified documents case

The high cost of giving birth even with insurance

Stem cell biologist probes earliest stages of human development

Virginia high school admissions case could be legal follow

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

knowledge

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Judge agrees to delay next hearing in Trump classified documents case

Pregnant women don't need prenatal multivitamins, study concludes

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

leisure time

hotspot

leisure time

hotspot